Acute effects of brain-responsive neurostimulation in drug-resistant partial onset epilepsy
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Acute effects of brain-responsive neurostimulation in drug-resistant partial onset epilepsy. / Rønborg, Søren N.; Esteller, Rosana; Tcheng, Thomas K.; Greene, David A.; Morrell, Martha J.; Wesenberg Kjaer, Troels; Arcot Desai, Sharanya.
I: Clinical Neurophysiology, Bind 132, Nr. 6, 2021, s. 1209-1220.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Acute effects of brain-responsive neurostimulation in drug-resistant partial onset epilepsy
AU - Rønborg, Søren N.
AU - Esteller, Rosana
AU - Tcheng, Thomas K.
AU - Greene, David A.
AU - Morrell, Martha J.
AU - Wesenberg Kjaer, Troels
AU - Arcot Desai, Sharanya
N1 - Publisher Copyright: © 2021 International Federation of Clinical Neurophysiology
PY - 2021
Y1 - 2021
N2 - Objective: Understanding the acute effects of responsive stimulation (AERS) based on intracranial EEG (iEEG) recordings in ambulatory patients with drug-resistant partial epilepsy, and correlating these with changes in clinical seizure frequency, may help clinicians more efficiently optimize responsive stimulation settings. Methods: In patients implanted with the NeuroPace® RNS® System, acute changes in iEEG spectral power following active and sham stimulation periods were quantified and compared within individual iEEG channels. Additionally, acute stimulation-induced acute iEEG changes were compared within iEEG channels before and after patients experienced substantial reductions in clinical seizure frequency. Results: Responsive stimulation resulted in a 20.7% relative decrease in spectral power in the 2–4 second window following active stimulation, compared to sham stimulation. On several detection channels, the AERS features changed when clinical outcomes improved but were relatively stable otherwise. AERS change direction associated with clinical improvement was generally consistent within detection channels. Conclusions: In this retrospective analysis, patients with drug-resistant partial epilepsy treated with direct brain-responsive neurostimulation showed an acute stimulation related reduction in iEEG spectral power that was associated with reductions in clinical seizure frequency. Significance: Identifying favorable stimulation related changes in iEEG activity could help physicians to more rapidly optimize stimulation settings for each patient.
AB - Objective: Understanding the acute effects of responsive stimulation (AERS) based on intracranial EEG (iEEG) recordings in ambulatory patients with drug-resistant partial epilepsy, and correlating these with changes in clinical seizure frequency, may help clinicians more efficiently optimize responsive stimulation settings. Methods: In patients implanted with the NeuroPace® RNS® System, acute changes in iEEG spectral power following active and sham stimulation periods were quantified and compared within individual iEEG channels. Additionally, acute stimulation-induced acute iEEG changes were compared within iEEG channels before and after patients experienced substantial reductions in clinical seizure frequency. Results: Responsive stimulation resulted in a 20.7% relative decrease in spectral power in the 2–4 second window following active stimulation, compared to sham stimulation. On several detection channels, the AERS features changed when clinical outcomes improved but were relatively stable otherwise. AERS change direction associated with clinical improvement was generally consistent within detection channels. Conclusions: In this retrospective analysis, patients with drug-resistant partial epilepsy treated with direct brain-responsive neurostimulation showed an acute stimulation related reduction in iEEG spectral power that was associated with reductions in clinical seizure frequency. Significance: Identifying favorable stimulation related changes in iEEG activity could help physicians to more rapidly optimize stimulation settings for each patient.
KW - Drug resistant epilepsy
KW - Electrical stimulation of the brain
KW - Epilepsy
KW - Intracranial EEG
KW - Neurostimulation
KW - Responsive neurostimulation
U2 - 10.1016/j.clinph.2021.03.013
DO - 10.1016/j.clinph.2021.03.013
M3 - Journal article
C2 - 33931295
AN - SCOPUS:85106119317
VL - 132
SP - 1209
EP - 1220
JO - Clinical Neurophysiology
JF - Clinical Neurophysiology
SN - 1388-2457
IS - 6
ER -
ID: 272170102